Oziltus Injection, Solution
Product Images NDC 70121-2701
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oziltus (NDC 70121-2701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton (Oziltus Denosumab Mobz Injection 2)
This is a description of a medication called Oziltus, which is available in single-dose vials containing 1.7 mL solution with 120 mg of denosumab-mobz. The components include glacial acetic acid, polysorbate 20, sorbitol, water for injection, USP, and sodium hydroxide to adjust pH. It is recommended to keep the medication refrigerated at 2°C to 8°C, protected from light, and not to freeze it. Once removed from the fridge, it must not be exposed to temperatures above 25°C and should be used within 14 days. Oziltus is for subcutaneous use only, with no preservatives, and should be administered by a healthcare provider. Each vial should be discarded if not used within 14 days. The medication is manufactured by Amneal Pharmaceuticals LLC and is a product of Spain. The National Drug Code (NDC) for this product is 70121-2701-1.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.